BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28545804)

  • 21. A randomized trial of lower leg and height growth in children with asthma treated with inhaled budesonide from a new dry powder inhaler.
    Gradman J; Wolthers OD
    Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e206-12. PubMed ID: 19298635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term lower leg growth in asthmatic children treated with inhaled beta2-agonists.
    Plomgaard AM; Schou AJ; Wolthers OD
    Ann Hum Biol; 2006; 33(2):135-41. PubMed ID: 16684688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: a randomized trial.
    Lin J; Kang J; Lee SH; Wang C; Zhou X; Crawford J; Jacques L; Stone S
    Respir Med; 2015 Jan; 109(1):44-53. PubMed ID: 25524507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD; Walters EG
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Braithwaite I; Williams M; Power S; Pilcher J; Weatherall M; Baines A; Moynihan J; Kempsford R; Beasley R;
    Respir Med; 2016 Oct; 119():115-121. PubMed ID: 27692131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of fluticasone furoate/umeclidinium in adult patients with asthma: a randomized, dose-ranging study.
    Lee LA; Yang S; Kerwin E; Trivedi R; Edwards LD; Pascoe S
    Respir Med; 2015 Jan; 109(1):54-62. PubMed ID: 25452139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.
    Bateman ED; Bleecker ER; Lötvall J; Woodcock A; Forth R; Medley H; Davis AM; Jacques L; Haumann B; Busse WW
    Respir Med; 2012 May; 106(5):642-50. PubMed ID: 22342538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover?
    Schou AJ; Heuck C; Wolthers OD
    Pediatr Pulmonol; 2003 Nov; 36(5):399-404. PubMed ID: 14520722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma.
    Woodcock A; Bleecker ER; Busse WW; Lötvall J; Snowise NG; Frith L; Jacques L; Haumann B; Bateman ED
    Respir Res; 2011 Dec; 12(1):160. PubMed ID: 22188590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate.
    Wolthers OD; Pedersen S
    Arch Dis Child; 1993 May; 68(5):673-6. PubMed ID: 8323338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol.
    Kempsford R; Allen A; Bareille P; Hamilton M; Cheesbrough A
    Clin Pharmacol Drug Dev; 2015 Jan; 4(1):2-11. PubMed ID: 27127998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
    LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children.
    Pedersen S; Agertoft L; Williams-Herman D; Kuznetsova O; Reiss TF; Knorr B; Dass SB; Wolthers OD
    Pediatr Pulmonol; 2007 Sep; 42(9):838-43. PubMed ID: 17659605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5-11 years with persistent asthma: A randomized trial.
    Oliver A; Allen A; VanBuren S; Hamilton M; Tombs L; Kempsford R; Qaqundah P
    Clin Pharmacol Drug Dev; 2014 Mar; 3(2):144-50. PubMed ID: 27128459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma.
    Bernstein DI; Bateman ED; Woodcock A; Toler WT; Forth R; Jacques L; Nunn C; O'Byrne PM
    J Asthma; 2015; 52(10):1073-83. PubMed ID: 26291137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.
    Dransfield MT; Feldman G; Korenblat P; LaForce CF; Locantore N; Pistolesi M; Watkins ML; Crim C; Martinez FJ
    Respir Med; 2014 Aug; 108(8):1171-9. PubMed ID: 24998880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic-pituitary-adrenocortical axis of children with asthma.
    Bareille P; Tomkins S; Imber V; Tayob M; Dunn K; Mehta R; Khindri S
    Allergy Asthma Clin Immunol; 2020; 16():11. PubMed ID: 32042286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing.
    Kempsford RD; Oliver A; Bal J; Tombs L; Quinn D
    Respir Med; 2013 Dec; 107(12):1873-80. PubMed ID: 24200619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.